risk factors

Androgen deprivation therapy (ADT) is the most common first therapy for men diagnosed with metastatic prostate cancer as well as many men with non-metastatic prostate cancer.  ADT brings with it many side effects including significant weight gain.  Weight gain, which may contribute to cardiovascular comorbidities as well as diabetes, is among the many adverse metabolic [...]